United States · FDA National Drug Code directory

URIMAR-T CAPS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 28595-224_2b39f5ac-ab4e-617a-e063-6294a90a4c48
Product NDC: 28595-224
Form: CAPSULE
Composition / generic term: methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate
Labeler: Allegis Pharmaceuticals, LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start / end (source format): 20230628
Source listing expiry: 20261231

Source-listed ingredients

METHENAMINE — 120 mg/1
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE — 40.8 mg/1
PHENYL SALICYLATE — 36.2 mg/1
METHYLENE BLUE — 10.8 mg/1
HYOSCYAMINE SULFATE — .12 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

60 CAPSULE in 1 BOTTLE (28595-224-60) · 28595-224-60

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →